Literature DB >> 29764743

Design, synthesis and evaluation of photoactivatable derivatives of microtubule (MT)-active [1,2,4]triazolo[1,5-a]pyrimidines.

Killian Oukoloff1, Jane Kovalevich2, Anne-Sophie Cornec3, Yuemang Yao2, Zachary A Owyang1, Michael James2, John Q Trojanowski2, Virginia M-Y Lee2, Amos B Smith3, Kurt R Brunden4, Carlo Ballatore5.   

Abstract

The [1,2,4]triazolo[1,5-a]pyrimidines comprise a promising class of non-naturally occurring microtubule (MT)-active compounds. Prior studies revealed that different triazolopyrimidine substitutions can yield molecules that either promote MT stabilization or disrupt MT integrity. These differences can have important ramifications in the therapeutic applications of triazolopyrimidines and suggest that different analogues may exhibit different binding modes within the same site or possibly interact with tubulin/MTs at alternative binding sites. To help discern these possibilities, a series of photoactivatable triazolopyrimidine congeners was designed, synthesized and evaluated in cellular assays with the goal of identifying candidate probes for photoaffinity labeling experiments. These studies led to the identification of different derivatives that incorporate a diazirine ring in the amine substituent at position 7 of the triazolopyrimidine heterocycle, resulting in molecules that either promote stabilization of MTs or disrupt MT integrity. These photoactivatable candidate probes hold promise to investigate the mode of action of MT-active triazolopyrimidines.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CNS drug discovery; Microtubule stabilization; Photoaffinity labeling; Triazolopyrimidine

Mesh:

Substances:

Year:  2018        PMID: 29764743      PMCID: PMC5993642          DOI: 10.1016/j.bmcl.2018.05.010

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  6 in total

Review 1.  1,2,4-Triazolo[1,5-a]pyrimidines in drug design.

Authors:  Killian Oukoloff; Bobby Lucero; Karol R Francisco; Kurt R Brunden; Carlo Ballatore
Journal:  Eur J Med Chem       Date:  2019-01-14       Impact factor: 6.514

2.  Brain-Penetrant Triazolopyrimidine and Phenylpyrimidine Microtubule Stabilizers as Potential Leads to Treat Human African Trypanosomiasis.

Authors:  Ludovica Monti; Steven C Wang; Killian Oukoloff; Amos B Smith; Kurt R Brunden; Conor R Caffrey; Carlo Ballatore
Journal:  ChemMedChem       Date:  2018-08-07       Impact factor: 3.466

3.  Evaluation of the Structure-Activity Relationship of Microtubule-Targeting 1,2,4-Triazolo[1,5-a]pyrimidines Identifies New Candidates for Neurodegenerative Tauopathies.

Authors:  Killian Oukoloff; Goodwell Nzou; Carmine Varricchio; Bobby Lucero; Thibault Alle; Jane Kovalevich; Ludovica Monti; Anne-Sophie Cornec; Yuemang Yao; Michael J James; John Q Trojanowski; Virginia M-Y Lee; Amos B Smith; Andrea Brancale; Kurt R Brunden; Carlo Ballatore
Journal:  J Med Chem       Date:  2021-01-07       Impact factor: 7.446

4.  Congeners Derived from Microtubule-Active Phenylpyrimidines Produce a Potent and Long-Lasting Paralysis of Schistosoma mansoni In Vitro.

Authors:  Ludovica Monti; Anne-Sophie Cornec; Killian Oukoloff; Jane Kovalevich; Kristen Prijs; Thibault Alle; Kurt R Brunden; Amos B Smith; Nelly El-Sakkary; Lawrence J Liu; Ali Syed; Danielle E Skinner; Carlo Ballatore; Conor R Caffrey
Journal:  ACS Infect Dis       Date:  2020-10-31       Impact factor: 5.084

5.  A brain-penetrant triazolopyrimidine enhances microtubule-stability, reduces axonal dysfunction and decreases tau pathology in a mouse tauopathy model.

Authors:  Bin Zhang; Yuemang Yao; Anne-Sophie Cornec; Killian Oukoloff; Michael J James; Pyry Koivula; John Q Trojanowski; Amos B Smith; Virginia M-Y Lee; Carlo Ballatore; Kurt R Brunden
Journal:  Mol Neurodegener       Date:  2018-11-07       Impact factor: 14.195

6.  Design, Synthesis and Biological Evaluation of [1,2,4]Triazolo[1,5-a]pyrimidine Indole Derivatives against Gastric Cancer Cells MGC-803 via the Suppression of ERK Signaling Pathway.

Authors:  Guang-Xi Yu; Ying Hu; Wei-Xin Zhang; Xin-Yi Tian; Sai-Yang Zhang; Yan Zhang; Shuo Yuan; Jian Song
Journal:  Molecules       Date:  2022-08-05       Impact factor: 4.927

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.